All stock lists
Anteris Technologies Global Corp. (NASDAQ:AVR)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
5.80-0.07 (-1.19%)
Insider Score
––Not scored
AVR Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AVR Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.01 M | 494.00 K | 310.00 K | 429.00 K | 618.00 K | 556.00 K |
| Revenue Growth (YoY) | 63.27 % | -11.15 % | -42.18 % | -44.21 % | -2.14 % | -27.42 % |
| Cost of Revenue | 233.00 K | 543.00 K | 514.00 K | 123.00 K | 148.00 K | 207.00 K |
| Gross Profit | 776.00 K | -49.00 K | -204.00 K | 306.00 K | 470.00 K | 349.00 K |
| SG&A Expense | 8.40 M | 6.50 M | 9.25 M | 0.00 | 0.00 | 0.00 |
| R&D Expense | 23.37 M | 17.46 M | 19.51 M | 16.81 M | 16.34 M | 16.46 M |
| Operating Expenses | 31.77 M | 23.96 M | 28.76 M | 22.57 M | 21.35 M | 22.13 M |
| Operating Income | -31.00 M | -24.01 M | -28.96 M | -22.27 M | -20.88 M | -21.78 M |
| Pretax Income | -28.78 M | -22.41 M | -29.02 M | -22.21 M | -21.06 M | -21.93 M |
| Tax Provision | 317.00 K | 492.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -29.10 M | -23.02 M | -29.20 M | -22.24 M | -20.83 M | -21.86 M |
| EPS (Basic) | -0.30 | -0.28 | -1.24 | -0.94 | -0.89 | -0.93 |
| EPS (Diluted) | -0.30 | -0.28 | -1.24 | -0.94 | -0.89 | -0.93 |
| Shares Outstanding | 97.34 M | 83.01 M | 23.58 M | 23.58 M | 23.58 M | 23.58 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.